acitretin has been researched along with Carcinoma, Epidermoid in 57 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (3.51) | 18.7374 |
1990's | 4 (7.02) | 18.2507 |
2000's | 20 (35.09) | 29.6817 |
2010's | 20 (35.09) | 24.3611 |
2020's | 11 (19.30) | 2.80 |
Authors | Studies |
---|---|
Allnutt, KJ; Brennand, S; Chong, AH; Davenport, R; Goh, MS; Li, J; Vogrin, S | 1 |
Chen, B; Jiang, B; Li, D; Liu, X; Yang, L; Ye, T; Yu, B; Zou, Y | 1 |
Farah, J; Farah, R; Weingarten, M | 1 |
Good, AJ; Herold, M; Longo, MI; Nielson, CB | 1 |
Badri, O; Karia, PS; Ruiz, ES; Schmults, CD | 1 |
Oh, CC; Sultana, R; Tam, SYC; Tee, LY | 1 |
Aung, PP; Curry, JL; Duke, TC; Glitza Oliva, IC; Ledesma, DA; Marques-Piubelli, ML; Nagarajan, P; Nelson, KC; Prieto, VG; Tetzlaff, MT; Torres-Cabala, CA; Wistuba, II | 1 |
El-Ghobashy, A; Elghobashy, M; Fox, E; Hamad, H; Moiemen, N | 1 |
Landow, SM; Lim, RK; Weinstock, MA | 1 |
Arzeno, J; Kim, J; Leavitt, E; Lonowski, S | 1 |
Bata, B; Currie, Z; Salvi, S; Tan, J; Wang, H | 1 |
Davidovici, B; Hodak, E; Reiss-Huss, S; Solomon-Cohen, E | 1 |
Kaffenberger, BH; Tian, F; Vaynshtok, PM | 1 |
Koh, WL; Oon, HH; Tan, WP | 1 |
Corry, A; Skillen, LA | 1 |
Cohen, DE; Miller, K; Stein, JA; Wu, TP | 1 |
Chong, AH; Cumming, S; Leung, V; Ng, JC | 1 |
Anforth, R; Blumetti, TC; Clements, A; Fernandez-Peñas, P; Kefford, R; Long, GV | 1 |
Chon, SY; Geddes, ER; Sambrano, BL | 1 |
Konda, S; O'Bryan, KW; Patel, VA; Ratner, D | 1 |
Butler, DF; Eduardo, C; Sutton, L | 1 |
Hibler, BP; Johnson-Jahangir, H; Rossi, AM | 1 |
Caglia, M; Hashemi, P; Kim, C; Shulman, K | 1 |
Chen, HD; Chen, J; He, CD; Jiang, Y; Jin, X; Lin, XY; Liu, M; Wang, KB; Wang, YK; Wei, HC; Xiao, T | 1 |
Anliker, M; Arnold, A; Binet, I; Hofbauer, GF; Hunger, R; Kempf, W; Laffitte, E; Lapointe, AC; Pascual, M; Pelloni, F; Serra, A | 1 |
Bowen, GM; Florell, SF; Hadley, JC; Hadley, ML; Tristani-Firouzi, P | 1 |
Bashir, SJ; Pichert, G; Robertson, SJ; Robson, A; Whittaker, S | 1 |
Delaney, T; Foxton, G | 1 |
Barysch, MJ; Dummer, R; Kamarashev, J; Lockwood, LL | 1 |
Abruzzese, C; Arcese, A; Bartolazzi, A; Camplone, G; Carlesimo, M; Cortesi, G; Narcisi, A; Orsini, D | 1 |
Alberts, SR; Barton, DL; Diekmann, BB; Kadakia, KC; Limburg, PJ; Loprinzi, CL; Novotny, PJ; Otley, CC; Pittelkow, MR; Sloan, JA | 1 |
Dellavalle, R; Francis, SO; Gamble, RG; Mason, MN; Prado, R; Wing, G | 1 |
Anforth, R; Blumetti, TC; Fernandez-Penas, P; Mohd Affandi, A | 1 |
Oakley, A; Simpkin, S | 1 |
Bannister, KM; George, R; Mathew, TH; Russ, GR; Weightman, W | 1 |
Agnew, KL; Bunker, CB | 1 |
Blokx, WA; de Jong, EM; de Wilde, PC; Ruiter, DJ; Smit, JV; van de Kerkhof, PC | 1 |
Cocuroccia, B; Girolomoni, G; Gubinelli, E; Posteraro, P | 1 |
Carrasco, D; Lebwohl, M; Tannis, C | 1 |
Khandpur, S; Sharma, VK | 1 |
Blokx, WA; de Jong, EM; de Sévaux, RG; Hoitsma, AJ; Smit, JV; van de Kerkhof, PC | 1 |
Bouwes Bavinck, JN; De Graaf, YG; Euvrard, S | 1 |
Atkins, CL; Brown, VL; Cerio, R; Ghali, L; Harwood, CA; Proby, CM | 1 |
Ran, L; Tan, S; Tan, W; Wang, W; Zeng, W; Zhang, R | 1 |
Le, K; Lim, A; Morrow, C; Samaraweera, U; See, A | 1 |
Haustein, UF; Paasch, U | 1 |
Cai, SQ; Chen, LR; Zheng, M | 2 |
Ansarin, H; Shaianfar, N; Tajziehchi, L | 1 |
Attard, N; Bunker, CB; Fearfield, L; Prasad, P; Schmulewitz, L; Thomas, HJ; Westaby, D | 1 |
Bichler, E; Dal-Pont, A; Moser, E | 1 |
Hamada, K; Kobayashi, K; Mori, M; Morita, E; Ninomiya, T; Okada, Y | 1 |
Bavinck, JN; Hermans, J; Tegzess, AM; ter Schegget, J; Tieben, LM; Van der Woude, FJ; Vermeer, BJ | 1 |
Bergoend, H; Delaporte, E; Feingold, N; Janin, A; N'guyen-Mailfer, C; Piette, F; Savary, JB; Vasseur, F | 1 |
de Rooij, MJ; van de Kerkhof, PC | 1 |
Artemi, P; Kossard, S | 1 |
elAttar, TM; Lin, HS | 1 |
6 review(s) available for acitretin and Carcinoma, Epidermoid
Article | Year |
---|---|
Use of Topical and Systemic Retinoids in Solid Organ Transplant Recipients: Update and Review of the Current Literature.
Topics: Acitretin; Administration, Cutaneous; Administration, Oral; Carcinoma, Squamous Cell; Dermatologic Agents; Dermatology; Evidence-Based Medicine; Graft Rejection; Humans; Immunosuppressive Agents; Isotretinoin; Keratosis, Actinic; Organ Transplantation; Skin Neoplasms; Transplant Recipients; Treatment Outcome; Warts | 2019 |
Efficacy and Cost Analysis for Acitretin for Basal and Squamous Cell Carcinoma Prophylaxis in Renal Transplant Recipients.
Topics: Acitretin; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Costs and Cost Analysis; Humans; Keratolytic Agents; Kidney Transplantation; Skin Neoplasms; Transplant Recipients | 2021 |
Chemoprevention of keratinocyte carcinoma and actinic keratosis in solid-organ transplant recipients: Systematic review and meta-analyses.
Topics: Acitretin; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Humans; Keratosis, Actinic; Niacinamide; Organ Transplantation; Randomized Controlled Trials as Topic; Skin Neoplasms; Transplant Recipients; Treatment Outcome | 2021 |
Nonmelanoma skin cancer chemoprevention.
Topics: Acitretin; Aminolevulinic Acid; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Deoxyribonuclease (Pyrimidine Dimer); Eflornithine; Humans; Monoterpenes; Peroxisome Proliferator-Activated Receptors; Photochemotherapy; Photosensitizing Agents; Polyphenols; Retinoids; Skin Neoplasms; Viral Proteins | 2011 |
Acitretin suppression of squamous cell carcinoma: case report and literature review.
Topics: Acitretin; Adult; Carcinoma, Squamous Cell; Humans; Keratolytic Agents; Male; Psoriasis; PUVA Therapy; Skin Neoplasms; Treatment Outcome | 2003 |
Systemic and topical retinoids in the management of skin cancer in organ transplant recipients.
Topics: Acitretin; Administration, Oral; Administration, Topical; Anticarcinogenic Agents; Carcinoma, Squamous Cell; Chemoprevention; Etretinate; Humans; Organ Transplantation; Precancerous Conditions; Retinoids; Skin Neoplasms | 2004 |
5 trial(s) available for acitretin and Carcinoma, Epidermoid
Article | Year |
---|---|
Randomized controlled trial of acitretin versus placebo in patients at high-risk for basal cell or squamous cell carcinoma of the skin (North Central Cancer Treatment Group Study 969251).
Topics: Acitretin; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Double-Blind Method; Female; Humans; Male; Middle Aged; Neoplasms, Second Primary; Placebos; Retinoids; Risk; Skin Neoplasms; Time Factors | 2012 |
Acitretin for chemoprevention of non-melanoma skin cancers in renal transplant recipients.
Topics: Acitretin; Adult; Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cross-Over Studies; Female; Humans; Kidney Transplantation; Male; Middle Aged; Prospective Studies; Skin Neoplasms | 2002 |
Acitretin treatment in (pre)malignant skin disorders of renal transplant recipients: Histologic and immunohistochemical effects.
Topics: Acitretin; Adult; Apoptosis; Biopsy; Carcinoma, Squamous Cell; Epidermal Cells; Epidermis; Female; Humans; Immunohistochemistry; Keratolytic Agents; Keratosis; Kidney Transplantation; Male; Middle Aged; Precancerous Conditions; Skin Neoplasms | 2004 |
Safety and efficacy of 5% imiquimod cream for the treatment of skin dysplasia in high-risk renal transplant recipients: randomized, double-blind, placebo-controlled trial.
Topics: Acitretin; Adjuvants, Immunologic; Administration, Topical; Adult; Aged; Aminoquinolines; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Double-Blind Method; Female; Humans; Imiquimod; Immunosuppression Therapy; Keratolytic Agents; Kidney Transplantation; Male; Middle Aged; Ointments; Precancerous Conditions; Risk Factors; Skin; Skin Neoplasms | 2005 |
Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study.
Topics: Acitretin; Adult; Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Chi-Square Distribution; Double-Blind Method; Female; Humans; Keratosis; Kidney Transplantation; Male; Middle Aged; Skin Neoplasms | 1995 |
46 other study(ies) available for acitretin and Carcinoma, Epidermoid
Article | Year |
---|---|
A long-term cohort study of acitretin for prevention of keratinocyte carcinoma in solid organ transplant recipients.
Topics: Acitretin; Australia; Carcinoma, Squamous Cell; Cohort Studies; Humans; Keratinocytes; Organ Transplantation; Retrospective Studies; Skin Neoplasms | 2022 |
Acitretin enhances the cytotoxic effect of 5-aminolevulinic acid photodynamic therapy on squamous cell carcinoma cells.
Topics: Acitretin; Aminolevulinic Acid; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Humans; Photochemotherapy; Photosensitizing Agents; Reactive Oxygen Species; Skin Neoplasms | 2022 |
Treatment of Reactive Keratoacanthomas with Acitretin Following Multiple Excisions and Mohs Surgery for Recurrent Squamous Cell Carcinoma.
Topics: Acitretin; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Humans; Keratoacanthoma; Mohs Surgery; Neoplasm Recurrence, Local; Skin Neoplasms | 2022 |
Hypertrophic lichenoid dermatitis immune-related adverse event during combined immune checkpoint and exportin inhibitor therapy: A diagnostic pitfall for superficially invasive squamous cell carcinoma.
Topics: Acitretin; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Dermatitis; Drug Eruptions; Drug Therapy, Combination; Exportin 1 Protein; Female; Fluocinonide; Glucocorticoids; Humans; Hypertrophy; Immune Checkpoint Inhibitors; Karyopherins; Keratolytic Agents; Lichenoid Eruptions; Melanoma; Programmed Cell Death 1 Receptor; Receptors, Cytoplasmic and Nuclear; Treatment Outcome; Triamcinolone | 2020 |
Oral retinoid, acitretin, is effective in the management of resistant recurrent vulval verrucous carcinoma: A case report.
Topics: Acitretin; Carcinoma, Squamous Cell; Carcinoma, Verrucous; Female; Humans; Neoplasm Recurrence, Local; Vulvar Neoplasms | 2020 |
Acitretin for Secondary Prevention of Keratinocyte Cancers in a Veteran Population: A Retrospective Cohort Study.
Topics: Acitretin; Aged; Aged, 80 and over; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Drug Prescriptions; Female; Follow-Up Studies; Hospitals, Veterans; Humans; Male; Neoplasm Recurrence, Local; Retrospective Studies; Secondary Prevention; Skin; Skin Neoplasms; Veterans | 2021 |
Current Practices for Preventative Interventions for Nonmelanoma Skin Cancers Among Dermatologic Surgeons.
Topics: Acitretin; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Dermatologic Agents; Humans; Institutional Practice; Keratosis, Actinic; Mohs Surgery; Niacinamide; Practice Patterns, Physicians'; Private Practice; Skin Neoplasms; Surveys and Questionnaires; Vitamin B Complex | 2021 |
Systemic acitretin in the management of periocular squamous cell carcinoma.
Topics: Acitretin; Carcinoma, Squamous Cell; Humans; Skin Neoplasms | 2021 |
Low-Dose Acitretin for Secondary Prevention of Keratinocyte Carcinomas in Solid-Organ Transplant Recipients.
Topics: Acitretin; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cross-Over Studies; Female; Humans; Keratinocytes; Keratolytic Agents; Male; Middle Aged; Organ Transplantation; Postoperative Complications; Retrospective Studies; Secondary Prevention; Skin Neoplasms; Treatment Outcome | 2022 |
Acitretin amelioration of Acrokeratosis Paraneoplastica (Bazex Syndrome) in cases of incurable squamous cell carcinoma of the hypopharynx.
Topics: Acitretin; Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Hypotrichosis; Keratolytic Agents; Male; Middle Aged; Paraneoplastic Syndromes; Skin Diseases; Skin Neoplasms; Squamous Cell Carcinoma of Head and Neck | 2016 |
Acitretin-Altered Squamous Cell Carcinoma: A Pitfall in Diagnosis.
Topics: Acitretin; Aged; Carcinoma, Squamous Cell; Diagnosis, Differential; Female; Humans; Keratolytic Agents; Male; Psoriasis; PUVA Therapy; Skin Neoplasms | 2019 |
Combination therapy of sirolimus and acitretin in solid organ transplant recipients: a new cutaneous adverse event.
Topics: Acitretin; Aged; Carcinoma, Squamous Cell; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Keratolytic Agents; Male; Organ Transplantation; Sirolimus; Skin Neoplasms; Transplant Recipients; Wound Healing | 2019 |
Keratoacanthomas arising in association with prurigo nodules in pruritic, actinically damaged skin.
Topics: Acitretin; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Cryotherapy; Cyclosporine; Dermatologic Agents; Eczema; Female; Humans; Keratoacanthoma; Keratolytic Agents; Keratosis, Actinic; Prurigo; Pruritus; Retrospective Studies | 2013 |
Accrual of non-melanoma skin cancer in renal-transplant recipients: experience of a Victorian tertiary referral institution.
Topics: Acitretin; Adult; Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Humans; Immunosuppression Therapy; Keratolytic Agents; Kidney Transplantation; Male; Middle Aged; Occupational Exposure; Prospective Studies; Skin Neoplasms; Sunlight; Tertiary Care Centers; Victoria | 2014 |
Systemic retinoids for the chemoprevention of cutaneous squamous cell carcinoma and verrucal keratosis in a cohort of patients on BRAF inhibitors.
Topics: Acitretin; Aged; Anticarcinogenic Agents; Carcinoma, Squamous Cell; Cohort Studies; Female; Humans; Imidazoles; Indoles; Keratolytic Agents; Keratosis; Male; Melanoma; Middle Aged; Oximes; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Skin Neoplasms; Sulfonamides; Vemurafenib | 2013 |
Vemurafenib-related cutaneous side effects ameliorated by acitretin.
Topics: Acitretin; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemoprevention; Disease Progression; Female; Follow-Up Studies; Humans; Indoles; Keratolytic Agents; Melanoma; Middle Aged; Neoplasm Staging; Skin Neoplasms; Sulfonamides; Vemurafenib | 2014 |
Fibrohistiocytic tumors in a lung transplant patient taking oral capecitabine for nonmelanoma skin cancer chemoprevention.
Topics: Acitretin; Aged; Antimetabolites, Antineoplastic; Capecitabine; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Deoxycytidine; Fatal Outcome; Fluorouracil; Graft vs Host Disease; Head and Neck Neoplasms; Histiocytoma, Malignant Fibrous; Humans; Keratolytic Agents; Lung Transplantation; Male; Skin Neoplasms | 2014 |
Diffuse lichenplanopilaris and multiple squamous neoplasms.
Topics: Acitretin; Aged; Carcinoma, Squamous Cell; Dermatitis; Female; Humans; Hypertrophy; Keratoacanthoma; Keratolytic Agents; Lichen Planus; Skin Diseases; Skin Neoplasms | 2015 |
Serum Sirolimus Level Elevation Induced by Acitretin: Report of a Novel Drug-Drug Interaction.
Topics: Acitretin; Carcinoma, Squamous Cell; Drug Interactions; Humans; Immunosuppressive Agents; Keratolytic Agents; Kidney Transplantation; Male; Middle Aged; Sirolimus; Skin Neoplasms | 2015 |
Treatment of Imiquimod Resistant Epidermodysplasia Verruciformis With Ingenol Mebutate.
Topics: Acitretin; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Diterpenes; Drug Resistance; Epidermodysplasia Verruciformis; Female; Gels; Humans; Imiquimod; Keratolytic Agents; Rare Diseases; Skin Neoplasms; Treatment Outcome; Tretinoin | 2016 |
Acitretin induces apoptosis through CD95 signalling pathway in human cutaneous squamous cell carcinoma cell line SCL-1.
Topics: Acitretin; Apoptosis; Carcinoma, Squamous Cell; Caspases; Cell Line, Tumor; Cell Proliferation; Enzyme Activation; Fas Ligand Protein; fas Receptor; Fas-Associated Death Domain Protein; Gene Expression Regulation, Neoplastic; Humans; Protein Binding; RNA, Messenger; Signal Transduction; Skin Neoplasms | 2009 |
Swiss clinical practice guidelines for skin cancer in organ transplant recipients.
Topics: Acitretin; Anticarcinogenic Agents; Carcinoma, Squamous Cell; Humans; Immunocompromised Host; Organ Transplantation; Skin Neoplasms; Sunscreening Agents | 2009 |
Case series of multiple recurrent reactive keratoacanthomas developing at surgical margins.
Topics: Acitretin; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Fluorouracil; Forearm; Humans; Injections, Intralesional; Keratoacanthoma; Keratolytic Agents; Male; Methotrexate; Recurrence; Skin Neoplasms | 2009 |
Severe exacerbation of multiple self-healing squamous epithelioma (Ferguson-Smith disease) with radiotherapy, which was successfully treated with acitretin.
Topics: Acitretin; Carcinoma, Squamous Cell; Facial Neoplasms; Humans; Keratoacanthoma; Keratolytic Agents; Male; Middle Aged; Neoplasms, Multiple Primary; Neoplasms, Radiation-Induced; Neoplastic Syndromes, Hereditary; Skin Neoplasms | 2010 |
Eruptive keratoacanthoma and squamous cell carcinoma complicating imiquimod therapy: response to oral acitretin.
Topics: Acitretin; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Humans; Imiquimod; Keratoacanthoma; Keratolytic Agents; Skin Neoplasms; Treatment Outcome | 2011 |
Successful treatment of multiple keratoacanthoma with topical imiquimod and low-dose acitretin.
Topics: Acitretin; Administration, Oral; Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma; Carcinoma, Squamous Cell; Female; Humans; Imiquimod; Keratoacanthoma; Keratolytic Agents; Skin Neoplasms | 2011 |
Efficacy of acitretin in the treatment of squamous cell carcinoma of the oral cavity.
Topics: Acitretin; Carcinoma, Squamous Cell; Female; Humans; Keratolytic Agents; Middle Aged; Mouth Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Systemic retinoid therapy for chemoprevention of nonmelanoma skin cancer in a patient treated with vemurafenib.
Topics: Acitretin; Aged; Carcinoma, Squamous Cell; Humans; Indoles; Keratolytic Agents; Male; Melanoma; Retinoids; Skin Neoplasms; Sulfonamides; Vemurafenib | 2012 |
Multiple eruptive squamous cell carcinoma in a patient with chronic plaque psoriasis on adalimumab.
Topics: Acitretin; Adalimumab; Aged; Antibodies, Monoclonal, Humanized; Carcinoma, Squamous Cell; Humans; Immunosuppressive Agents; Keratolytic Agents; Male; Psoriasis; Skin Neoplasms | 2013 |
Multiple cutaneous squamous carcinoma in a psoriatic associated with ciclosporin, alcohol abuse and ultraviolet radiation exposure which were suppressed by acitretin.
Topics: Acitretin; Alcoholism; Carcinoma, Squamous Cell; Cyclosporine; Humans; Immunosuppressive Agents; Keratolytic Agents; Leg; Male; Middle Aged; Psoriasis; PUVA Therapy; Skin Neoplasms; Ultraviolet Rays | 2003 |
Immunohistochemical effects of temporary cessation of long-term acitretin treatment in keratinocytic intraepidermal neoplasia of renal transplant recipients.
Topics: Acitretin; Carcinoma, Squamous Cell; Female; Follow-Up Studies; Humans; Keratolytic Agents; Keratosis; Kidney Transplantation; Male; Middle Aged; Skin Neoplasms; Time Factors; Withholding Treatment | 2003 |
Epidermodysplasia verruciformis with multiple mucosal carcinomas treated with pegylated interferon alfa and acitretin.
Topics: Acitretin; Adult; Antiviral Agents; Carcinoma, Squamous Cell; Drug Therapy, Combination; Epidermodysplasia Verruciformis; Female; Humans; Interferon alpha-2; Interferon-alpha; Keratolytic Agents; Papillomaviridae; Recombinant Proteins; Skin Neoplasms | 2003 |
Successful treatment of multiple premalignant and malignant lesions in arsenical keratosis with a combination of acitretin and intralesional 5-fluorouracil.
Topics: Acitretin; Arsenic; Biopsy, Needle; Bowen's Disease; Carcinoma, Squamous Cell; Drug Therapy, Combination; Fluorouracil; Follow-Up Studies; Humans; Immunohistochemistry; India; Injections, Intralesional; Keratosis; Male; Middle Aged; Precancerous Conditions; Skin Neoplasms; Treatment Outcome; Water Pollutants | 2003 |
Effects of ATRA, acitretin and tazarotene on growth and apoptosis of Tca8113 cells.
Topics: Acitretin; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Humans; Nicotinic Acids; Tongue Neoplasms; Tretinoin | 2005 |
Multiple squamous cell carcinomas in a patient with mycosis fungoides.
Topics: Acitretin; Carcinoma, Squamous Cell; Humans; Keratolytic Agents; Leg; Male; Middle Aged; Mycosis Fungoides; Neoplasms, Second Primary; Radiotherapy; Skin Neoplasms; Treatment Outcome | 2005 |
Aggressive undifferentiated squamous cell carcinoma in an immunosuppressed patient after kidney transplantation.
Topics: Acitretin; Adjuvants, Immunologic; Administration, Oral; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Counseling; Cyclosporine; Follow-Up Studies; Humans; Imiquimod; Immunocompromised Host; Immunosuppressive Agents; Keratolytic Agents; Keratosis; Kidney Transplantation; Male; Middle Aged; Ointments; Skin; Skin Neoplasms; Sunscreening Agents; Time Factors | 2005 |
[Acitretin induces apoptosis and changes of relative signaling pathway in epidermoid carcinoma cell line A431].
Topics: Acitretin; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Humans; Signal Transduction; Skin Neoplasms | 2006 |
[Effects of acitretin on the expression of signaling pathway-related genes in epidermal squamous-cell carcinoma cells].
Topics: Acitretin; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cyclin D1; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; RNA, Messenger; Signal Transduction; STAT3 Transcription Factor | 2006 |
A case of epidermodysplasia verruciformis with squamous cell carcinomas on non-sun-exposed areas of skin.
Topics: Acitretin; Adult; Carcinoma, Squamous Cell; Epidermodysplasia Verruciformis; Humans; Keratolytic Agents; Male; Skin Neoplasms; Skin Pigmentation | 2007 |
An unusual cutaneous-polyposis syndrome stabilized with acitretin.
Topics: Acitretin; Adenomatous Polyps; Carcinoma, Squamous Cell; Female; Genes, Neoplasm; Humans; Intestinal Polyposis; Keratolytic Agents; Liver; Middle Aged; Skin Neoplasms; Syndrome; Treatment Outcome | 2008 |
[Effect of an aromatic retinoid on human squamous cell carcinomas in vitro].
Topics: Acid Phosphatase; Acitretin; Carcinoma, Squamous Cell; Culture Techniques; Dose-Response Relationship, Drug; Humans; Laryngeal Neoplasms; Lysosomes; Mouth Neoplasms; Tretinoin | 1982 |
[Antitumor effects of aromatic retinoids (Ro 10-1670, Ro 10-9359) on the chemically-induced epithelial tumors].
Topics: 9,10-Dimethyl-1,2-benzanthracene; Acitretin; Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cricetinae; Etretinate; Mesocricetus; Mice; Neoplasms, Experimental; Papilloma; Skin Neoplasms; Tretinoin | 1982 |
Keratoderma with scleroatrophy of the extremities or sclerotylosis (Huriez syndrome): a reappraisal.
Topics: Acitretin; Adult; Carcinoma, Squamous Cell; DNA Repair; Drug Therapy, Combination; Etretinate; Female; Genetic Linkage; Humans; Keratoderma, Palmoplantar; Keratolytic Agents; Male; Middle Aged; Pedigree; Skin Neoplasms | 1995 |
Multiple squamous cell carcinomas in a psoriatic patient following high-dose photochemotherapy and cyclosporin treatment: response to long-term acitretin maintenance.
Topics: Acitretin; Carcinoma, Squamous Cell; Cyclosporine; Humans; Immunosuppressive Agents; Keratolytic Agents; Male; Middle Aged; Neoplasms, Multiple Primary; Psoriasis; PUVA Therapy; Skin Neoplasms | 1997 |
Acitretin for hypertrophic lichen planus-like reaction in a burn scar.
Topics: Acitretin; Biopsy; Burns; Carcinoma, Squamous Cell; Cicatrix, Hypertrophic; Diagnosis, Differential; Humans; Keratolytic Agents; Leg; Lichen Planus; Male; Middle Aged; Skin Neoplasms | 2000 |
In vitro inhibition of prostaglandin biosynthesis in squamous cell carcinoma by retinoids.
Topics: Acitretin; Arachidonic Acid; Arachidonic Acids; Benzoates; Carcinoma, Squamous Cell; Dinoprostone; Dose-Response Relationship, Drug; Etretinate; Humans; Prostaglandin-Endoperoxide Synthases; Retinoids; Tongue Neoplasms; Tretinoin; Tumor Cells, Cultured | 1990 |